Emerging Therapies in β-Thalassemia.
Rayan Bou-Fakhredin1, Kevin H M Kuo2, Ali T Taher3
1Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Hematology/Oncology Clinics of North America
|March 12, 2023
Summary
Novel therapies for beta-thalassemia are emerging, targeting key disease mechanisms like globin imbalance, ineffective red blood cell production, and iron overload. These advancements offer new hope for treating this genetic blood disorder.
Area of Science:
- Hematology
- Genetics
- Pharmacology
Background:
- Beta-thalassemia is a serious inherited blood disorder characterized by reduced or absent synthesis of beta-globin chains.
- Pathophysiological understanding has advanced, paving the way for new treatment strategies.
Purpose of the Study:
- To provide an overview of emerging therapeutic modalities for beta-thalassemia.
- To categorize novel therapies based on their targeted pathophysiological mechanisms.
Main Methods:
- Literature review of current research and clinical trials.
- Classification of therapies into three main categories.
Main Results:
- Emerging therapies target three key areas: correcting alpha/beta globin chain imbalance, addressing ineffective erythropoiesis, and managing iron dysregulation.
- Several novel therapeutic approaches are in various stages of development.
Conclusions:
- Advances in understanding beta-thalassemia pathophysiology are driving the development of innovative treatments.
- These new therapies hold promise for improving outcomes in patients with beta-thalassemia.
Keywords:
Advancement of careClinical trialNovel therapiesQuality of lifeTransfusion burdenβ-ThalassemiaMore Related Videos
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
371
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
371
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
00:59Gene Therapy
25.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.7K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
212
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
212
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
540
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
540
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K